FDA Advisory Panel Votes to Require Updated Warnings
On December 8, 2011, an FDA advisory panel held 9 hours of hearings about Yaz and Yasmin birth control and the risk of blood clots. Testimony included information about several large, independent studies that showed an increased risk. The panel also heard from the family of a young woman who used another birth control for months with no problems. She switched to Yaz, ...
continue reading...